posted on 2012-04-12, 00:00authored byDante Rotili, Alberta Samuele, Domenico Tarantino, Rino Ragno, Ira Musmuca, Flavio Ballante, Giorgia Botta, Ludovica Morera, Marco Pierini, Roberto Cirilli, Maxim
B. Nawrozkij, Emmanuel Gonzalez, Bonaventura Clotet, Marino Artico, José A. Esté, Giovanni Maga, Antonello Mai
The single enantiomers of two pyrimidine-based HIV-1
non-nucleoside
reverse transcriptase inhibitors, 1 (MC1501) and 2 (MC2082), were tested in both cellular and enzyme assays.
In general, the R forms were more potent than their S counterparts and racemates and (R)-2 was more efficient than (R)-1 and the reference compounds, with some exceptions. Interestingly,
(R)-2 displayed a faster binding to
K103N RT with respect to WT RT, while (R)-1 showed the opposite behavior.